# BRISTOL-MYERS SQUIBB COMPANY (BMY) FY2025 Q1 P&L / Income Statement - Company: BRISTOL-MYERS SQUIBB COMPANY (BMY) - Period: 2025-01-01 to 2025-03-31 - Filing: Q1 FY2025 10-Q, filed 2025-04-24, accession number 0000014272-25-000091 - Page: https://plicit.ai/financials/bmy/fy2025-q1-income-statement - Chart image: https://plicit.ai/charts/bmy-fy2025-q1-income-statement-sankey.png ## Chart details: Revenue by Product and Service Income statement for 2025-01-01 through 2025-03-31. View: Product and service (Disaggregation of Revenue by Product and Region). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 11,201,000,000 US dollars - **Cost of products sold**: 3,033,000,000 US dollars - **Gross profit (calculated)**: 8,168,000,000 US dollars - **Operating expenses (calculated)**: 5,197,000,000 US dollars - **Operating profit (calculated)**: 2,971,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(Loss) before income taxes**: 2,971,000,000 US dollars - **Income tax provision**: 509,000,000 US dollars - **Net earnings/(loss)**: 2,462,000,000 US dollars - **Opdivo**: 2,265,000,000 US dollars - **Opdivo Qvantig**: 9,000,000 US dollars - **Orencia**: 770,000,000 US dollars - **Yervoy**: 624,000,000 US dollars - **Reblozyl**: 478,000,000 US dollars - **Opdualag**: 252,000,000 US dollars - **Breyanzi**: 263,000,000 US dollars - **Camzyos**: 159,000,000 US dollars - **Zeposia**: 107,000,000 US dollars - **Abecma**: 103,000,000 US dollars - **Sotyktu**: 55,000,000 US dollars - **Krazati**: 48,000,000 US dollars - **Cobenfy**: 27,000,000 US dollars - **Other Growth products**: 403,000,000 US dollars - **Eliquis**: 3,565,000,000 US dollars - **Revlimid**: 936,000,000 US dollars - **Pomalyst/Imnovid**: 658,000,000 US dollars - **Sprycel**: 175,000,000 US dollars - **Abraxane**: 105,000,000 US dollars - **Other Legacy products**: 199,000,000 US dollars - **Selling, general and administrative**: 1,584,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development**: 2,257,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Acquired IPRD**: 188,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Amortization of acquired intangible assets**: 830,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Other (income)/expense, net**: 339,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (2) - Page: https://plicit.ai/financials/bmy/fy2025-q1-income-statement/revenue-by-product-and-service-2 - Chart image: https://plicit.ai/charts/bmy-fy2025-q1-revenue-by-product-and-service-2-sankey.png Income statement for 2025-01-01 through 2025-03-31. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 11,201,000,000 US dollars - **Cost of products sold**: 3,033,000,000 US dollars - **Gross profit (calculated)**: 8,168,000,000 US dollars - **Operating expenses (calculated)**: 5,197,000,000 US dollars - **Operating profit (calculated)**: 2,971,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(Loss) before income taxes**: 2,971,000,000 US dollars - **Income tax provision**: 509,000,000 US dollars - **Net earnings/(loss)**: 2,462,000,000 US dollars - **Net product sales**: 10,886,000,000 US dollars - **Alliance and other revenues**: 315,000,000 US dollars - **Selling, general and administrative**: 1,584,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development**: 2,257,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Acquired IPRD**: 188,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Amortization of acquired intangible assets**: 830,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Other (income)/expense, net**: 339,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (3) - Page: https://plicit.ai/financials/bmy/fy2025-q1-income-statement/revenue-by-product-and-service-3 - Chart image: https://plicit.ai/charts/bmy-fy2025-q1-revenue-by-product-and-service-3-sankey.png Income statement for 2025-01-01 through 2025-03-31. View: Product and service (Disaggregation of Revenue). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 11,201,000,000 US dollars - **Cost of products sold**: 3,033,000,000 US dollars - **Gross profit (calculated)**: 8,168,000,000 US dollars - **Operating expenses (calculated)**: 5,197,000,000 US dollars - **Operating profit (calculated)**: 2,971,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(Loss) before income taxes**: 2,971,000,000 US dollars - **Income tax provision**: 509,000,000 US dollars - **Net earnings/(loss)**: 2,462,000,000 US dollars - **Net product sales**: 10,886,000,000 US dollars - **Other revenues**: 227,000,000 US dollars - **Undisclosed (calculated)**: 88,000,000 US dollars - **Selling, general and administrative**: 1,584,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development**: 2,257,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Acquired IPRD**: 188,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Amortization of acquired intangible assets**: 830,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Other (income)/expense, net**: 339,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Geography - Page: https://plicit.ai/financials/bmy/fy2025-q1-income-statement/revenue-by-geography - Chart image: https://plicit.ai/charts/bmy-fy2025-q1-revenue-by-geography-sankey.png Income statement for 2025-01-01 through 2025-03-31. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 11,201,000,000 US dollars - **Cost of products sold**: 3,033,000,000 US dollars - **Gross profit (calculated)**: 8,168,000,000 US dollars - **Operating expenses (calculated)**: 5,197,000,000 US dollars - **Operating profit (calculated)**: 2,971,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(Loss) before income taxes**: 2,971,000,000 US dollars - **Income tax provision**: 509,000,000 US dollars - **Net earnings/(loss)**: 2,462,000,000 US dollars - **UNITED STATES**: 7,873,000,000 US dollars - **International**: 3,110,000,000 US dollars - **Other**: 218,000,000 US dollars - **Selling, general and administrative**: 1,584,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development**: 2,257,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Acquired IPRD**: 188,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Amortization of acquired intangible assets**: 830,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Other (income)/expense, net**: 339,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (4) - Page: https://plicit.ai/financials/bmy/fy2025-q1-income-statement/revenue-by-product-and-service-4 - Chart image: https://plicit.ai/charts/bmy-fy2025-q1-revenue-by-product-and-service-4-sankey.png Income statement for 2025-01-01 through 2025-03-31. View: Product and service (Reconciliation of Gross Product Sales to Net Product Sales). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 11,201,000,000 US dollars - **Cost of products sold**: 3,033,000,000 US dollars - **Gross profit (calculated)**: 8,168,000,000 US dollars - **Operating expenses (calculated)**: 5,197,000,000 US dollars - **Operating profit (calculated)**: 2,971,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(Loss) before income taxes**: 2,971,000,000 US dollars - **Income tax provision**: 509,000,000 US dollars - **Net earnings/(loss)**: 2,462,000,000 US dollars - **Gross product sales**: 19,874,000,000 US dollars - **Net product sales**: 10,886,000,000 US dollars - **Selling, general and administrative**: 1,584,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development**: 2,257,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Acquired IPRD**: 188,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Amortization of acquired intangible assets**: 830,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Other (income)/expense, net**: 339,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Revenue before reconciliation (calculated)**: 30,760,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation. - **Components above reported revenue (calculated)**: negative 19,559,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue. ## Chart details: Revenue by Product and Service by Arrangement - Page: https://plicit.ai/financials/bmy/fy2025-q1-income-statement/revenue-by-product-and-service-by-arrangement - Chart image: https://plicit.ai/charts/bmy-fy2025-q1-revenue-by-product-and-service-by-arrangement-sankey.png Income statement for 2025-01-01 through 2025-03-31. View: Product and Service by Collaborative Arrangement and Arrangement Other than Collaborative. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 11,201,000,000 US dollars - **Cost of products sold**: 3,033,000,000 US dollars - **Gross profit (calculated)**: 8,168,000,000 US dollars - **Operating expenses (calculated)**: 5,197,000,000 US dollars - **Operating profit (calculated)**: 2,971,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(Loss) before income taxes**: 2,971,000,000 US dollars - **Income tax provision**: 509,000,000 US dollars - **Net earnings/(loss)**: 2,462,000,000 US dollars - **Other revenues**: 227,000,000 US dollars - **Cobenfy**: 27,000,000 US dollars - **Eliquis**: 3,565,000,000 US dollars - **Opdivo**: 2,265,000,000 US dollars - **Orencia**: 770,000,000 US dollars - **Yervoy**: 624,000,000 US dollars - **Alliance revenues - Collaborative Arrangement**: 88,000,000 US dollars - **Net product sales - Collaborative Arrangement**: 3,635,000,000 US dollars - **Selling, general and administrative**: 1,584,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development**: 2,257,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Acquired IPRD**: 188,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Amortization of acquired intangible assets**: 830,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Other (income)/expense, net**: 339,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.